Latest News

Early antiretroviral treatment may preserve key immune responses to HIV

Instituting combination antiretroviral (ART) treatment at the earliest stages of HIV infection may allow the generation of functional CD8 “killer” T cells and preservation of the CD4 helper T cells that are the virus’s primary target. Investigators from the Ragon Institute of MGH, MIT and Harvard describe the results of their study, conducted among South African women at risk for contracting the virus, in Science Translational Medicine.

Source link

Related posts

Black mothers get less treatment for postpartum depression than other moms


Glow-In-The-Dark Paper Test Rapidly Detects Infectious Diseases


Lightning Myths And Misconceptions


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy